AIRS

MKT CAP:$175M

AirSculpt Technologies, Inc.

Market Cap

$175M

Healthcare·Medical - Care Facilities·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$2.50+$0.65 (+35.14%)

Apr 22, 2026

Company Details

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. It offers custom body contouring ...

CEO

Yogesh Jashnani

IPO Date

Oct 29, 2021

Website

www.elitebodysculpture.com

Key Metrics TTM

Revenue

$158M

-16.5% YoY

Net Income

-$18M

EPS (Diluted)

-$0.30

Free Cash Flow

$2M

Revenue / Share

$2.62

Gross Margin

64.0%

Operating Margin

-9.3%

Net Margin

-11.4%

FCF Margin

1.6%

P/S

1.1x

P/E

—

Earnings Reports

Q4 2025

May 1, 2026

PENDING

FY 2025

Mar 31, 2026

$152M-15.8%EPS -$0.19

Q3 2025

Nov 7, 2025

$35M-17.8%EPS -$0.15

Q2 2025

Aug 1, 2025

$44M-13.7%EPS -$0.01

Q1 2025

May 2, 2025

$39M-17.3%EPS -$0.05

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q3 21	$35M	$24M	$10M
Q1 22	$40M	$25M	-$1M
Q2 22	$50M	$33M	$4M
Q3 22	$39M	$25M	-$1M
Q4 22	$41M	$26M	-$6M
Q1 23	$46M	$29M	$2M
Q2 23	$56M	$37M	$5M
Q3 23	$47M	$30M	$955.0K
Q4 23	$48M	$30M	$1M
Q1 24	$48M	$27M	$11M
Q2 24	$51M	$34M	-$5M
Q3 24	$43M	$27M	-$4M
Q4 24	$39M	$24M	-$4M
Q1 25	$39M	$25M	-$2M
Q2 25	$44M	$29M	$786.0K
Q3 25	$35M	$23M	-$10M

Valuation

Quarter	P/S	P/E
Q3 21	7.5x	33.1x
Q1 22	5.7x	31.9x
Q2 22	2.4x	20.9x
Q3 22	2.3x	657.2x
Q4 22	1.5x	—
Q1 23	1.7x	—
Q2 23	2.7x	—
Q3 23	2.1x	—
Q4 23	2.3x	—
Q1 24	1.7x	219.2x
Q2 24	1.2x	—
Q3 24	1.5x	—
Q4 24	1.8x	—
Q1 25	0.8x	—
Q2 25	1.7x	—
Q3 25	2.8x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 21	$9M	$7M
Q1 22	$7M	$3M
Q2 22	$10M	$9M
Q3 22	$329.0K	-$4M
Q4 22	$7M	$4M
Q1 23	$6M	$2M
Q2 23	$12M	$10M
Q3 23	$635.0K	-$1M
Q4 23	$5M	$3M
Q1 24	$3M	$2M
Q2 24	$3M	-$576.0K
Q3 24	$2M	-$3M
Q4 24	$3M	-$815.0K
Q1 25	$868.0K	-$1M
Q2 25	$5M	$5M
Q3 25	-$225.0K	-$405.0K

Capital Expenditures

Quarter	CapEx
Q3 21	$2M
Q1 22	$4M
Q2 22	$2M
Q3 22	$5M
Q4 22	$2M
Q1 23	$4M
Q2 23	$2M
Q3 23	$2M
Q4 23	$2M
Q1 24	$2M
Q2 24	$4M
Q3 24	$5M
Q4 24	$4M
Q1 25	$2M
Q2 25	$265.0K
Q3 25	$180.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 21	+213.8%	+130.2%
Q1 22	+258.1%	+274.4%
Q2 22	+89.9%	+141.3%
Q3 22	+11.2%	+69.4%
Q4 22	+17.5%	+86.4%
Q1 23	+15.9%	+8.2%
Q2 23	+12.2%	+10.2%
Q3 23	+20.3%	+13.8%
Q4 23	+17.0%	-1.0%
Q1 24	+3.9%	-16.9%
Q2 24	-8.4%	+11.2%
Q3 24	-9.1%	+0.9%
Q4 24	-17.7%	-6.3%
Q1 25	-17.3%	+11.9%
Q2 25	-13.7%	-22.8%
Q3 25	-17.8%	-3.3%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 21	$86.0K	0.2%
Q1 22	$7M	18.5%
Q2 22	$7M	14.7%
Q3 22	$7M	18.9%
Q4 22	$7M	18.4%
Q1 23	$4M	9.6%
Q2 23	$5M	8.3%
Q3 23	$4M	9.6%
Q4 23	$5M	10.0%
Q1 24	-$7M	-14.2%
Q2 24	$5M	9.6%
Q3 24	$3M	8.1%
Q4 24	$2M	5.7%
Q1 25	$1M	3.1%
Q2 25	$1M	3.1%
Q3 25	$1M	3.2%

OpEx Breakdown

Quarter	G&A	S&M	SG&A
Q3 21	$8M	$4M	—
Q1 22	$19M	$5M	—
Q2 22	$22M	$5M	—
Q3 22	$19M	$5M	—
Q4 22	$24M	$5M	—
Q1 23	$19M	$6M	—
Q2 23	$20M	$9M	—
Q3 23	$20M	$7M	—
Q4 23	—	—	$26M
Q1 24	$7M	$8M	—
Q2 24	$23M	$13M	—
Q3 24	$20M	$7M	—
Q4 24	$18M	$7M	—
Q1 25	$16M	$7M	—
Q2 25	$14M	$10M	—
Q3 25	$16M	$6M	—

Revenue Segments

Quarter	Reportable Segment
Q1 25	$39M
Q2 25	$44M
Q3 25	$35M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$27M	$0	$27M
Q2 22	$35M	$0	$35M
Q3 22	$8M	$0	$8M
Q4 22	$10M	$0	$10M
Q1 23	$11M	$0	$11M
Q2 23	$21M	$0	$21M
Q3 23	$9M	$0	$9M
Q4 23	$10M	$0	$10M
Q1 24	$11M	$0	$11M
Q2 24	$10M	$0	$10M
Q3 24	$6M	$0	$6M
Q4 24	$8M	$0	$8M
Q1 25	$6M	$0	$6M
Q2 25	$8M	$0	$8M
Q3 25	$5M	$0	$5M
Q4 25	$8M	$0	$8M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q3 21	55M	-0.5%	-0.5%
Q1 22	56M	+0.5%	0.0%
Q2 22	58M	+4.9%	+4.9%
Q3 22	56M	-4.7%	0.0%
Q4 22	56M	+0.6%	+1.1%
Q1 23	56M	+0.8%	+1.4%
Q2 23	59M	+3.7%	+0.3%
Q3 23	57M	-3.0%	+2.1%
Q4 23	57M	+0.6%	+2.0%
Q1 24	58M	+2.2%	+3.5%
Q2 24	58M	-1.5%	-1.6%
Q3 24	58M	+0.2%	+1.5%
Q4 24	58M	+0.8%	+1.7%
Q1 25	59M	+0.7%	+0.2%
Q2 25	59M	+0.9%	+2.6%
Q3 25	60M	+1.9%	+4.4%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q3 21	—	—
Q1 22	$164.8K	240
Q2 22	$206.9K	240
Q3 22	$162.1K	240
Q4 22	$139.9K	291
Q1 23	$157.4K	291
Q2 23	$191.4K	291
Q3 23	$160.8K	291
Q4 23	$137.6K	346
Q1 24	$137.6K	346
Q2 24	$147.4K	346
Q3 24	$123.0K	346
Q4 24	$100.7K	389
Q1 25	$101.2K	389
Q2 25	$113.1K	389
Q3 25	$90.0K	389

Revenue / Employee